Trial Profile
A Phase 2, Randomized, Double-blind, Placebo-controlled, add-on Study of DS-8500a in Japanese Patients With Type 2 Diabetes Mellitus Receiving Sitagliptin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Firuglipel (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 11 Nov 2016 Status changed from active, no longer recruiting to completed.
- 25 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 24 Aug 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Sep 2016.